|

27
- 30 May 2005
|
SETTING
AND UPSETTING IMPRINTS: IMPLICATIONS FOR ART
Jacquetta M Trasler
McGill University-Montreal Children’s
Hospital Research Institute and the Departments
of Pediatrics
Human Genetics and Pharmacology & Therapeutics
McGill University
Montreal
Canada
|
A number of studies published over that last few
years have suggested that there is an increased
incidence of rare genomic imprinting disorders associated
with alterations in the methylation of imprinted
genes in children conceived by human assisted reproductive
technologies (ART).
Genomic imprinting is initiated in the germline,
persists through preimplantation development and
involves the formation of an epigenetic ‘mark’
at specific loci in a parent-of-origin-specific
manner, such that a subset of genes is expressed
monoallelically in the resulting offspring. ART
includes hormonal stimulation protocols as well
as the isolation, handling and culture of gametes
and early embryos at times when imprinted genes
are likely to be particularly vulnerable to external
influences.
The most well studied epigenetic ‘mark’
that distinguishes the maternal and paternal alleles
of imprinted genes is DNA methylation. To better
understand how genomic imprinting defects could
be related to ART we have used the mouse model to:1)
examine the methylation status of several imprinted
genes during male and female germ cell development,
2) determine the expression and roles of the DNA
methyltransferase (Dnmt) enzymes in establishing
and maintaining gametic imprints, and 3) examined
effects of superovulation and culture conditions
on imprinted gene methylation.
Bisulfite sequencing was used to determine the methylation
status of multiple CpG sites in imprinted genes
as well as the timing of paternal and maternal methylation
imprint establishment in the two germ lines. In
the male, the H19 methylation imprint is initiated
prenatally during embryonic germ cell development
and is complete by the pachytene phase of postnatal
spermatogenesis.
In contrast, examination of the methylation status
of Igf2r, Snrpn, Peg1 and Peg3 during oocyte development
identified the postnatal growth phase (post-pachytene)
of oogenesis as the crucial period during which
maternal imprints are set down in the female. Thus
methylation imprints are established at different
developmental times in the parental germ lines,
suggesting that male and female germ cells may be
susceptible to conditions that perturb imprints
at sex-specific stages of prenatal and postnatal
gametogenesis.
Expression studies and gene-targeting experiments
have been used to determine the roles of the Dnmt
enzymes in imprinting. The recently discovered Dnmt3
enzymes, Dnmt3a, Dnmt3b, and Dnmt3l are developmentally
expressed during postnatal oocyte growth, with Dnmt3l
transcripts being particularly abundant. Dnmt1 and
the three Dnmt3 enzymes are differentially expressed
in a stage-dependent manner in prenatal and postnatal
male germ cells, coinciding with the timing of methylation
establishment and maintenance in the male germ line.
Gene-targeting experiments by others indicate essential
roles for the Dnmt3 enzymes in establishing methylation
imprints.
Results to date suggest that the different Dnmt
enzymes perform distinct functions during germ cell
development and early embryogenesis. In preliminary
studies we have compared the methylation of Snrpn
and H19 in embryos derived from naturally cycling
versus superovulated females.
The results suggest that some imprinted genes such
as H19, which are known to be sensitive to alterations
in culture conditions, may be affected by superovulation,
while others, such as Snrpn, may be more resistant.
Similar results were seen in oocyte culture experiments.
Our studies suggest the need for more research to
model techniques used in ARTs and test for epigenetic
effects in the offspring.
List
of abstracts from the 3rd International Conference
on the Female Reproductive Tract